LEAP2 reduces postprandial glucose excursions and ad libitum food intake in healthy men
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kojima, 1999, Ghrelin is a growth-hormone-releasing acylated peptide from stomach, Nature, 402, 656, 10.1038/45230
Ariyasu, 2001, Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans, J. Clin. Endocrinol. Metab., 86, 4753, 10.1210/jcem.86.10.7885
Mani, 2019, LEAP2 changes with body mass and food intake in humans and mice, J. Clin. Invest., 129, 3909, 10.1172/JCI125332
Ge, 2018, LEAP2 is an endogenous antagonist of the ghrelin receptor, Cell Metab., 27, 461, 10.1016/j.cmet.2017.10.016
M’Kadmi, 2019, N-terminal liver-expressed antimicrobial peptide 2 (LEAP2) region exhibits inverse agonist activity toward the ghrelin receptor, J. Med. Chem., 62, 965, 10.1021/acs.jmedchem.8b01644
Hagemann, 2021, Identification and metabolic profiling of a novel human gut-derived LEAP2 fragment, J. Clin. Endocrinol. Metab., 106, e966, 10.1210/clinem/dgaa803
Baldini, 2019, The melanocortin pathway and control of appetite-progress and therapeutic implications, J. Endocrinol., 241, R1, 10.1530/JOE-18-0596
Maciejewski, 2016, Bariatric surgery and long-term durability of weight loss, JAMA Surg., 151, 1046, 10.1001/jamasurg.2016.2317
Moffett, 2021, The altered enteroendocrine reportoire following roux-en-Y-gastric bypass as an effector of weight loss and improved glycaemic control, Appetite, 156, 104807, 10.1016/j.appet.2020.104807
Svane, 2016, Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery, Int. J. Obes., 40, 1699, 10.1038/ijo.2016.121
Cornejo, 2021, The ups and downs of growth hormone secretagogue receptor signaling, FEBS J., 288, 7213, 10.1111/febs.15718
Druce, 2005, Ghrelin increases food intake in obese as well as lean subjects, Int. J. Obes., 29, 1130, 10.1038/sj.ijo.0803001
Islam, 2020, Liver-expressed antimicrobial peptide 2 antagonizes the effect of ghrelin in rodents, J. Endocrinol., 244, 13, 10.1530/JOE-19-0102
Shankar, 2021, LEAP2 deletion in mice enhances ghrelin’s actions as an orexigen and growth hormone secretagogue, Mol. Metab., 53, 101327, 10.1016/j.molmet.2021.101327
Barrile, 2019, Development of a novel fluorescent ligand of growth hormone secretagogue receptor based on the N-Terminal Leap2 region, Mol. Cell. Endocrinol., 498, 110573, 10.1016/j.mce.2019.110573
Gupta, 2021, High coexpression of the ghrelin and LEAP2 receptor GHSR with pancreatic polypeptide in mouse and human islets, Endocrinology, 162, bqab148, 10.1210/endocr/bqab148
Cornejo, 2019, Growth hormone secretagogue receptor signalling affects high-fat intake independently of plasma levels of ghrelin and LEAP2, in a 4-day binge eating model, J. Neuroendocrinol., 31, e12785, 10.1111/jne.12785
Levin, 2006, Ghrelin stimulates gastric emptying and hunger in normal-weight humans, J. Clin. Endocrinol. Metab., 91, 3296, 10.1210/jc.2005-2638
Willems, 2001, How useful is paracetamol absorption as a marker of gastric emptying? A systematic literature study, Dig. Dis. Sci., 46, 2256, 10.1023/A:1011935603893
Takaya, 2000, Ghrelin strongly stimulates growth hormone (GH) release in humans, J. Clin. Endocrinol. Metab., 85, 4908, 10.1210/jcem.85.12.7167
Traynard, 2020, Efficient pharmacokinetic modeling workflow with the MonolixSuite: a case study of remifentanil, CPT Pharmacometrics Syst. Pharmacol., 9, 198, 10.1002/psp4.12500
Flint, 1998, Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans, J. Clin. Invest., 101, 515, 10.1172/JCI990
Fujikawa, 2021, Central regulation of glucose metabolism in an insulin-dependent and -independent manner, J. Neuroendocrinol., 33, e12941, 10.1111/jne.12941
Møller, 2009, Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects, Endocr. Rev., 30, 152, 10.1210/er.2008-0027
DiGruccio, 2016, Comprehensive alpha, beta and delta cell transcriptomes reveal that ghrelin selectively activates delta cells and promotes somatostatin release from pancreatic islets, Mol. Metab., 5, 449, 10.1016/j.molmet.2016.04.007
Adriaenssens, 2016, Transcriptomic profiling of pancreatic alpha, beta and delta cell populations identifies delta cells as a principal target for ghrelin in mouse islets, Diabetologia, 59, 2156, 10.1007/s00125-016-4033-1
Lawlor, 2017, Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes, Genome Res., 27, 208, 10.1101/gr.212720.116
Svendsen, 2021, Paracrine regulation of somatostatin secretion by insulin and glucagon in mouse pancreatic islets, Diabetologia, 64, 142, 10.1007/s00125-020-05288-0
Lauritzen, 2020, Increased lipolysis after infusion of acylated ghrelin: a randomized, double-blinded placebo-controlled trial in hypopituitary patients, Clin. Endocrinol. (Oxf)., 93, 672, 10.1111/cen.14290
Nass, 2008, Evidence for acyl-ghrelin modulation of growth hormone release in the fed state, J. Clin. Endocrinol. Metab., 93, 1988, 10.1210/jc.2007-2234
Hartman, 1993, Evaluation of pulsatile patterns of growth hormone release in humans: a brief review, Am. J. Hum. Biol., 5, 603, 10.1002/ajhb.1310050603
Zigman, 2005, Mice lacking ghrelin receptors resist the development of diet-induced obesity, J. Clin. Invest., 115, 3564, 10.1172/JCI26002
Flint, 2000, Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies, Int. J. Obes., 24, 38, 10.1038/sj.ijo.0801083
Reeves, 2004, Reducing the time period of steady state does not affect the accuracy of energy expenditure measurements by indirect calorimetry, J. Appl. Physiol., 97, 130, 10.1152/japplphysiol.01212.2003
Sanchez-Delgado, 2018, Reliability of resting metabolic rate measurements in young adults: impact of methods for data analysis, Clin. Nutr., 37, 1618, 10.1016/j.clnu.2017.07.026
Fuller-Jackson, 2020, Effect of sex and sex steroids on brown adipose tissue heat production in humans, Eur. J. Endocrinol., 183, 343, 10.1530/EJE-20-0184
El Hadi, 2016, Infrared thermography for indirect assessment of activation of brown adipose tissue in lean and obese male subjects, Physiol. Meas., 37, N118, 10.1088/0967-3334/37/12/N118
Thuzar, 2018, Glucocorticoids suppress brown adipose tissue function in humans: a double-blind placebo-controlled study, Diabetes Obes. Metab., 20, 840, 10.1111/dom.13157
Orskov, 1991, Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine, J. Clin. Invest., 87, 415, 10.1172/JCI115012